Nicotinamide adenine dinucleotide suppresses epileptogenesis at an early stage

The pathophysiologic mechanisms of epileptogenesis are poorly understood, and no effective therapy exists for suppressing epileptogenesis. Numerous reports have shown that nicotinamide adenine dinucleotide (NAD(+)) has neuroprotective effects, suggesting its potential use for treating epileptogenesi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Sci Rep
Egile Nagusiak: Liu, Juan, Yang, Beimeng, Zhou, Pei, Kong, Yingying, Hu, Weiwei, Zhu, Geng, Ying, Weihai, Li, Weidong, Wang, Yun, Li, Shengtian
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5544671/
https://ncbi.nlm.nih.gov/pubmed/28779137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-07343-0
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak